Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.05 - $24.02 $194,940 - $259,416
10,800 Added 62.07%
28,200 $523,000
Q2 2024

Aug 14, 2024

SELL
$18.65 - $28.5 $117,494 - $179,550
-6,300 Reduced 26.58%
17,400 $336,000
Q1 2024

May 15, 2024

SELL
$24.74 - $35.13 $1.22 Million - $1.74 Million
-49,400 Reduced 67.58%
23,700 $639,000
Q4 2023

Feb 14, 2024

BUY
$21.62 - $37.21 $866,962 - $1.49 Million
40,100 Added 121.52%
73,100 $2.62 Million
Q3 2023

Nov 15, 2023

SELL
$27.34 - $55.37 $683,500 - $1.38 Million
-25,000 Reduced 43.1%
33,000 $932,000
Q2 2023

Aug 23, 2023

BUY
$26.1 - $49.92 $1.09 Million - $2.08 Million
41,600 Added 253.66%
58,000 $2.9 Million
Q1 2023

May 15, 2023

SELL
$18.09 - $27.61 $258,687 - $394,823
-14,300 Reduced 46.58%
16,400 $412,000
Q4 2022

Feb 14, 2023

BUY
$16.24 - $26.38 $25,983 - $42,208
1,600 Added 5.5%
30,700 $574,000
Q3 2022

Nov 14, 2022

SELL
$23.95 - $34.71 $311,350 - $451,230
-13,000 Reduced 30.88%
29,100 $734,000
Q2 2022

Aug 15, 2022

BUY
$21.39 - $35.9 $331,545 - $556,450
15,500 Added 58.27%
42,100 $1.16 Million
Q1 2022

May 16, 2022

SELL
$24.84 - $36.12 $474,444 - $689,892
-19,100 Reduced 41.79%
26,600 $914,000
Q4 2021

Feb 14, 2022

BUY
$33.38 - $59.25 $423,926 - $752,475
12,700 Added 38.48%
45,700 $1.57 Million
Q3 2021

Nov 12, 2021

SELL
$53.75 - $76.55 $860,000 - $1.22 Million
-16,000 Reduced 32.65%
33,000 $1.8 Million
Q2 2021

Aug 06, 2021

BUY
$59.02 - $78.8 $1.28 Million - $1.71 Million
21,700 Added 79.49%
49,000 $3.81 Million
Q1 2021

May 14, 2021

BUY
$64.61 - $113.09 $271,362 - $474,978
4,200 Added 18.18%
27,300 $1.96 Million
Q4 2020

Feb 12, 2021

BUY
$48.06 - $84.4 $682,452 - $1.2 Million
14,200 Added 159.55%
23,100 $1.89 Million
Q3 2020

Nov 13, 2020

BUY
$46.87 - $93.33 $417,143 - $830,637
8,900 New
8,900 $423,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.22B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.